Get started
Tonix Pharmaceuticals Holding Corp.Tonix Pharmaceuticals Holding Corp.Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TNXP chart


Full chart

TNXP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪75.34 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−20.5574 USD
Net income (FY)
‪−116.66 M‬ USD
Revenue (FY)
‪7.77 M‬ USD
Shares float
‪186.89 M‬
Beta (1Y)
−0.49

Employees


Employees (FY)
103
Change (1Y)
−14 −11.97%
Revenue / Employee (1Y)
‪75.42 K‬ USD
Net income / Employee (1Y)
‪−1.13 M‬ USD

About Tonix Pharmaceuticals Holding Corp.


Sector
Health Technology
CEO
Seth Lederman
Headquarters
Chatham
Website
tonixpharma.com
Founded
2007
FIGI
BBG000LG8XM5
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TNXP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TNXP is 0.3853 USD — it has decreased by −4.42% in the past 24 hours. Watch Tonix Pharmaceuticals Holding Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tonix Pharmaceuticals Holding Corp. stocks are traded under the ticker TNXP.
TNXP stock has fallen by −69.66% compared to the previous week, the month change is a 97.29% rise, over the last year Tonix Pharmaceuticals Holding Corp. has showed a −96.82% decrease.
We've gathered analysts' opinions on Tonix Pharmaceuticals Holding Corp. future price: according to them, TNXP price has a max estimate of 4.00 USD and a min estimate of 2.50 USD. Watch TNXP chart and read a more detailed Tonix Pharmaceuticals Holding Corp. stock forecast: see what analysts think of Tonix Pharmaceuticals Holding Corp. and suggest that you do with its stocks.
TNXP reached its all-time high on Feb 8, 2012 with the price of 263,680,000.0000 USD, and its all-time low was 0.1180 USD and was reached on Oct 3, 2024. View more price dynamics on TNXP chart.
See other stocks reaching their highest and lowest prices.
TNXP stock is 17.27% volatile and has beta coefficient of −0.49. Track Tonix Pharmaceuticals Holding Corp. stock price on the chart and check out the list of the most volatile stocks — is Tonix Pharmaceuticals Holding Corp. there?
Today Tonix Pharmaceuticals Holding Corp. has the market capitalization of ‪72.01 M‬, it has increased by 20.72% over the last week.
Yes, you can track Tonix Pharmaceuticals Holding Corp. financials in yearly and quarterly reports right on TradingView.
Tonix Pharmaceuticals Holding Corp. is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
TNXP earnings for the last quarter are −0.23 USD per share, whereas the estimation was −3.88 USD resulting in a 94.07% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about Tonix Pharmaceuticals Holding Corp. earnings.
Tonix Pharmaceuticals Holding Corp. revenue for the last quarter amounts to ‪2.82 M‬ USD, despite the estimated figure of ‪3.15 M‬ USD. In the next quarter, revenue is expected to reach ‪3.20 M‬ USD.
TNXP net income for the last quarter is ‪−14.21 M‬ USD, while the quarter before that showed ‪−78.78 M‬ USD of net income which accounts for 81.96% change. Track more Tonix Pharmaceuticals Holding Corp. financial stats to get the full picture.
No, TNXP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 103.00 employees. See our rating of the largest employees — is Tonix Pharmaceuticals Holding Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tonix Pharmaceuticals Holding Corp. EBITDA is ‪−78.19 M‬ USD, and current EBITDA margin is ‪−1.47 K‬%. See more stats in Tonix Pharmaceuticals Holding Corp. financial statements.
Like other stocks, TNXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tonix Pharmaceuticals Holding Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tonix Pharmaceuticals Holding Corp. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tonix Pharmaceuticals Holding Corp. stock shows the sell signal. See more of Tonix Pharmaceuticals Holding Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.